Mattila Jyrki 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 24, 2019
Insider Transaction Report
Form 4
Mattila Jyrki
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-05-22−15,000→ 0 totalExercise: $37.64Exp: 2025-04-22→ Common Stock (15,000 underlying) - Sale
Common Stock, $0.001 par value
2019-05-22$62.06/sh−18,750$1,163,625→ 376 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-22−3,750→ 11,250 totalExercise: $41.82Exp: 2028-03-15→ Common Stock (3,750 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2019-05-22$37.64/sh+15,000$564,600→ 15,376 total - Exercise/Conversion
Common Stock, $0.001 par value
2019-05-22$41.82/sh+3,750$156,825→ 19,126 total
Footnotes (2)
- [F1]The options were granted on April 22, 2015 and vested in four equal annual installments beginning on the first anniversary of the grant date.
- [F2]The options were granted on March 15, 2018, and vest in four equal annual installments beginning on the first anniversary of the grant date.